IL36G and systemic lupus erythematosus: Active SLE patients (SLEDAI (Systemic Lupus Erythematosus Disease Activity Index) score ≥5) exhibited significantly higher serum levels of IL-36α and IL-36γ than the inactive patients (SLEDAI score ≤4).